表紙
市場調査レポート

生体弁の世界市場:2016〜2020年

Global Tissue Heart Valves Market 2016-2020

発行 TechNavio (Infiniti Research Ltd.) 商品コード 353214
出版日 ページ情報 英文 41 Pages
即納可能
価格
本日の銀行送金レート: 1USD=101.50円で換算しております。
Back to Top
生体弁の世界市場:2016〜2020年 Global Tissue Heart Valves Market 2016-2020
出版日: 2016年02月24日 ページ情報: 英文 41 Pages
概要

心臓弁には機械弁と生体弁があります。生体弁は牛豚、ヒトの組織など様々なものが用いられます。機械弁と比べ、生体弁は生涯にわたって抗凝血剤を使用する必要がありません。世界の医療施設では、毎年30万件の心臓弁置換手術が行なわれています。世界の生体弁市場は、2016〜2020年にかけCAGR3.81%で拡大すると予測されています。

当レポートでは、世界の生体弁市場の現状と今後の成長見通し、地域別動向とともに、市場の動向と課題、主要ベンダーのプロファイルなどをまとめています。

第1章 エグゼクティブサマリー

第2章 当レポートの範囲

第3章 市場調査方法

第4章 イントロダクション

  • 市場ハイライト

第5章 市況

  • 市場概要
  • 市場規模と予測
  • ファイブフォース分析

第6章 コスト分析

  • 弁置換術のコスト分析

第7章 製品別市場セグメンテーション

第8章 地域別セグメンテーション

  • 南北アメリカ
  • 欧州・中東・アフリカ
  • アジア太平洋地域

第9章 市場促進因子

  • 心臓弁疾患の罹患率
  • ステントレス生体弁の需要
  • 低侵襲性手術の導入
  • 高齢化

第10章 促進因子の影響

第11章 市場の課題

  • 代替製品の仕様
  • 潜在的合併症リスク
  • 熟練スタッフの不足
  • 厳しい法規制の枠組み

第12章 促進因子および課題の影響

第13章 市場動向

  • アジア太平洋地域における生体弁の需要
  • 高齢人口
  • M&Aの増加

第14章 ベンダー環境

  • 競合シナリオ
  • 市場シェア:2015年
  • Edwards Lifesciences
  • LivaNova
  • Medtronic
  • St. Jude Medical
  • その他の注目すべきベンダー

第15章 付録

第16章 Technavioについて

図表

目次
Product Code: IRTNTR8800

About Tissue Heart Valves

Heart valves are prosthetic cardiovascular medical devices that are used to replace a defective heart valve. These valves can be biological (tissue) or mechanical. Manufacturers develop tissue heart valves from various sources such as bovine, porcine, and human tissues. Devices developed using human tissues are known as allografts or homografts. The implantation of these devices does not require the lifelong use of blood-thinner medications compared to mechanical tissue heart valves. They also ensure unidirectional flow of the blood across heart chambers. The medical facilities worldwide perform about 300,000 heart valve replacement procedures each year.

Technavio's analysts forecast the global tissue heart valves market to grow at a CAGR of 3.81% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global tissue heart valves market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of tissue heart valve implants.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA

Technavio's report, Global Tissue Heart Valves Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

  • Edwards Lifesciences
  • LivaNova
  • Medtronic
  • St. Jude Medical

Other Prominent Vendors

  • Braile Biomedica
  • CryoLife
  • Labcor Laboratorios

Market driver

  • Demand for stentless tissue valves
  • For a full, detailed list, view our report

Market challenge

  • Lack of skilled personnel
  • For a full, detailed list, view our report

Market trend

  • Increase in M&A
  • For a full, detailed list, view our report

Key questions answered in this report

  • What will the market size be in 2020 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?

You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.

Table of Contents

PART 01: Executive summary

  • Highlights

PART 02: Scope of the report

  • Market overview
  • Top-vendor offerings

PART 03: Market research methodology

  • Research methodology
  • Economic indicators

PART 04: Introduction

  • Key market highlights

PART 05: Market landscape

  • Market overview
  • Market size and forecast
  • Five forces analysis

PART 06: Cost analysis

  • Cost analysis of valve replacement procedures

PART 07: Market segmentation by product

PART 08: Geographical segmentation

  • Tissue heart valves market in Americas
  • Tissue heart valves market in EMEA
  • Tissue heart valves market in APAC

PART 09: Market drivers

  • Prevalence of heart valve diseases
  • Demand for stentless tissue valves
  • Implementation of MI procedures
  • Rise in geriatric population

PART 10: Impact of drivers

PART 11: Market challenges

  • Use of alternative products
  • Risk of potential complications
  • Lack of skilled personnel
  • Stringent regulatory framework

PART 12: Impact of drivers and challenges

PART 13: Market trends

  • Demand for tissue heart valves in APAC
  • Preference among geriatric population
  • Increase in M&A

PART 14: Vendor landscape

  • Competitive scenario
  • Market share analysis 2015
  • Edwards Lifesciences
  • LivaNova
  • Medtronic
  • St. Jude Medical
  • Other prominent vendors

PART 15: Appendix

  • List of abbreviations

PART 16: Explore Technavio

List of Exhibits

  • Exhibit 01: Product offerings
  • Exhibit 02: Global tissue heart valves market 2015-2020 ($ billions)
  • Exhibit 03: Five forces analysis
  • Exhibit 04: Cost comparison of heart valve replacement procedures (high-risk group)
  • Exhibit 05: Global tissue heart valves market segmentation by product
  • Exhibit 06: Global tissue heart valves market segmentation by product 2015
  • Exhibit 07: Global tissue heart valves market segmentation by geography 2015
  • Exhibit 08: Global tissue heart valves market segmentation by geography 2020
  • Exhibit 09: Global tissue heart valves market segmentation by geography 2015-2020
  • Exhibit 10: Tissue heart valves market in Americas 2015-2020 ($ millions)
  • Exhibit 11: Tissue heart valves market in US 2015-2020 ($ millions)
  • Exhibit 12: Tissue heart valves market in EMEA 2015-2020 ($ millions)
  • Exhibit 13: Tissue heart valves market in APAC 2015-2020 ($ millions)
  • Exhibit 14: Impact of drivers
  • Exhibit 15: Impact of drivers and challenges
  • Exhibit 16: Cost comparison of heart valve replacement procedures
  • Exhibit 17: Ranking of top vendors 2015
  • Exhibit 18: Edwards Lifesciences: Key takeaways
  • Exhibit 19: LivaNova: Key takeaways
  • Exhibit 20: Medtronic: Key product offerings
  • Exhibit 21: Medtronic: Key takeaways
  • Exhibit 22: St. Jude Medical: Key takeaways
Back to Top